ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. The treatment involved taking a patient's own white blood cells, modifying them in a lab to target the CD22 protein on cancer cel…
Matched conditions: ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Ashwagandha under the microscope: 12-Month safety check begins
Knowledge-focused CompletedThis study followed 200 adults aged 18 to 65 who were already prescribed KSM-66 ashwagandha by their doctor. Over 12 months, researchers tracked side effects and lab results to see if long-term use is safe. The goal was to gather safety data, not to test a new treatment.
Matched conditions: ALL
Sponsor: SF Research Institute, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC